p63/p73 expression mediates cisplatin sensitivity in a subset of triple-negative primary breast cancer: Implications for a new clinical trial No significant financial relationships to disclose. This ...
Pretreatment neutrophil to lymphocyte ratio as a predictor of pathological complete response to neoadjuvant immunotherapy in early breast cancer. Targeted genotyping for recurring variants in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results